"Growth Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS).
- Growth Inhibitors
- Inhibitors, Growth
- Cell Growth Inhibitors
- Growth Inhibitors, Cell
- Inhibitors, Cell Growth
Below are MeSH descriptors whose meaning is more general than "Growth Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Growth Inhibitors".
This graph shows the total number of publications written about "Growth Inhibitors" by people in this website by year, and whether "Growth Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Growth Inhibitors" by people in Profiles.
CopA3 peptide induces permanent cell-cycle arrest in colorectal cancer cells. Mech Ageing Dev. 2021 06; 196:111497.
Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells. BMC Cancer. 2011 Oct 31; 11:468.
Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate cancer cells. Prostate. 2010 Jan 01; 70(1):27-36.
IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J Immunol. 2009 Aug 15; 183(4):2444-55.
Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth. J Biol Chem. 2007 Feb 09; 282(6):3428-32.
Knockdown of MBP-1 in human prostate cancer cells delays cell cycle progression. J Biol Chem. 2006 Aug 18; 281(33):23652-7.
The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. J Immunol. 2005 Aug 15; 175(4):2666-75.
Investigation of PKC isoform-specific translocation and targeting of the current of the late afterhyperpolarizing potential of myenteric AH neurons. Eur J Neurosci. 2005 Feb; 21(4):905-13.
Desulfovibrio alaskensis sp. nov., a sulphate-reducing bacterium from a soured oil reservoir. Int J Syst Evol Microbiol. 2004 Sep; 54(Pt 5):1747-1752.
Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol. 2004 Feb 01; 172(3):1426-36.